Literature DB >> 24872921

Cerebellar hemorrhage after embolization of ruptured vertebral dissecting aneurysm proximal to PICA including parent artery.

Akira Tamase1, Tomoya Kamide1, Kentaro Mori1, Yoshihisa Kitamura1, Hiroshi Shima1, Shunsuke Seki1, Motohiro Nomura1.   

Abstract

BACKGROUND: Some complications related to vertebral artery occlusion by endovascular technique have been reported. However, cerebellar hemorrhage after vertebral artery occlusion in subacute phase is rare. In this report, we describe a patient who showed cerebellar hemorrhage during hypertensive therapy for vasospasm after embolization of a vertebral dissecting aneurysm. CASE DESCRIPTION: A 56-year-old female with a ruptured vertebral dissecting aneurysm proximal to the posterior inferior cerebellar artery developed cerebellar hemorrhage 15 days after embolization of the vertebral artery, including the dissected site. In this patient, the preserved posterior inferior cerebellar artery fed by retrograde blood flow might have been hemodynamically stressed during hypertensive and antiplatelet therapies for subarachnoid hemorrhage, resulting in cerebellar hemorrhage.
CONCLUSION: Although cerebellar hemorrhage is not prone to occur in the nonacute stage of embolization of the vertebral artery, it should be taken into consideration that cerebellar hemorrhage may occur during hypertensive treatment.

Entities:  

Keywords:  Cerebellar hemorrhage; dissecting aneurysm; embolization; posterior inferior cerebellar artery; vertebral artery

Year:  2014        PMID: 24872921      PMCID: PMC4033783          DOI: 10.4103/2152-7806.131187

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


  9 in total

1.  Hyperperfusion phenomenon after percutaneous transluminal angioplasty for atherosclerotic stenosis of the intracranial vertebral artery. Case report.

Authors:  K Bando; K Satoh; S Matsubara; M Nakatani; S Nagahiro
Journal:  J Neurosurg       Date:  2001-05       Impact factor: 5.115

2.  Rebleeding from vertebral artery dissection after proximal clipping. Case report.

Authors:  C Kitanaka; T Morimoto; T Sasaki; K Takakura
Journal:  J Neurosurg       Date:  1992-09       Impact factor: 5.115

3.  Cerebellar hemorrhage after coil embolization for a ruptured vertebral dissecting aneurysm.

Authors:  M Nomura; S Kida; D Kita; T Kaneko; R Higashi; J Yoshikawa; O Matsui; J Yamashita
Journal:  Surg Neurol       Date:  2000-03

4.  Hemorrhagic complications after endovascular therapy for atherosclerotic intracranial arterial stenoses.

Authors:  Tomoaki Terada; Mitsuharu Tsuura; Hiroyuki Matsumoto; Osamu Masuo; Tomoyuki Tsumoto; Hiroo Yamaga; Yoshinori Ohura; Toru Itakura
Journal:  Neurosurgery       Date:  2006-08       Impact factor: 4.654

5.  Endovascular treatment of ruptured dissecting vertebral artery aneurysms--long-term follow-up results, benefits of early embolization, and predictors of outcome.

Authors:  Jong-Myong Lee; Tae-Sun Kim; Sung-Pil Joo; Woong Yoon; Ha-Young Choi
Journal:  Acta Neurochir (Wien)       Date:  2010-05-15       Impact factor: 2.216

6.  Endovascular treatment of intracranial vertebral artery dissections with stent placement or stent-assisted coiling.

Authors:  J Y Ahn; I B Han; T G Kim; P H Yoon; Y J Lee; B-H Lee; S H Seo; D I Kim; C K Hong; J Y Joo
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

7.  Endovascular management of vertebral artery dissecting aneurysms: review of 25 patients.

Authors:  Mahmoud M Taha; Hiroshi Sakaida; Fumio Asakura; Masayuki Maeda; Naoki Toma; Akitaka Yamamoto; Kenji Kawaguchi; Satoshi Matsushima; W Taki
Journal:  Turk Neurosurg       Date:  2010-04       Impact factor: 1.003

8.  Treatment of dissecting vertebral aneurysm.

Authors:  Y Kai; J Hamada; M Morioka; T Todaka; T Mizuno; Y Ushio
Journal:  Interv Neuroradiol       Date:  2002-01-10       Impact factor: 1.610

9.  Recurrent subarachnoid hemorrhage from untreated ruptured vertebrobasilar dissecting aneurysms.

Authors:  T Mizutani; T Aruga; T Kirino; Y Miki; I Saito; T Tsuchida
Journal:  Neurosurgery       Date:  1995-05       Impact factor: 4.654

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.